Double cord blood transplants: filling a niche?
- PMID: 17237545
- DOI: 10.1007/s12015-006-0013-z
Double cord blood transplants: filling a niche?
Abstract
Over the last decade, umbilical cord blood (CB) has become a viable option for hematopoietic stem cell transplants. A limiting factor has been the 10-fold lower cell dose in a CB unit compared with harvested bone marrow or peripheral blood stem cells. The low cell dose leads to delayed engraftment and an increase in graft failure. Double cord blood transplants represent a novel strategy to overcome this limitation. This review will cover the rationale behind and clinical results of double cord blood transplant studies. The chimerism data from these studies reveal that typically only one CB "wins the battle" for engraftment. These results may have important scientific implications in terms of understanding the nature of the hematopoietic stem cell niche and how modulation of this niche may impact transplant outcomes.
Similar articles
-
Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.Exp Hematol. 2005 Oct;33(10):1249-56. doi: 10.1016/j.exphem.2005.06.019. Exp Hematol. 2005. PMID: 16219548
-
Umbilical cord blood: biology and transplantation.Expert Rev Hematol. 2009 Apr;2(2):197-208. doi: 10.1586/ehm.09.9. Expert Rev Hematol. 2009. PMID: 21083452 Review.
-
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.Biol Blood Marrow Transplant. 2016 Jun;22(6):1065-1072. doi: 10.1016/j.bbmt.2016.02.010. Epub 2016 Feb 19. Biol Blood Marrow Transplant. 2016. PMID: 26912055 Free PMC article. Clinical Trial.
-
Transplantation and other uses of human umbilical cord blood and stem cells.Curr Pharm Des. 2007;13(13):1363-73. doi: 10.2174/138161207780618759. Curr Pharm Des. 2007. PMID: 17506721 Review.
-
Non-fucosylated CB CD34+ cells represent a good target for enforced fucosylation to improve engraftment following cord blood transplantation.Cytotherapy. 2017 Feb;19(2):285-292. doi: 10.1016/j.jcyt.2016.11.001. Epub 2016 Dec 2. Cytotherapy. 2017. PMID: 27919572
Cited by
-
Functional Integrity and Gene Expression Profiles of Human Cord Blood-Derived Hematopoietic Stem and Progenitor Cells Generated In Vitro.Stem Cells Transl Med. 2018 Aug;7(8):602-614. doi: 10.1002/sctm.18-0013. Epub 2018 Apr 26. Stem Cells Transl Med. 2018. PMID: 29701016 Free PMC article.
-
Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice.Exp Biol Med (Maywood). 2008 Aug;233(8):997-1012. doi: 10.3181/0802-RM-70. Exp Biol Med (Maywood). 2008. PMID: 18653783 Free PMC article.
-
Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?Blood. 2010 Oct 14;116(15):2706-12. doi: 10.1182/blood-2010-02-270942. Epub 2010 Jul 13. Blood. 2010. PMID: 20628146 Free PMC article.
-
Cell therapy in pediatric blood diseases.Front Med (Lausanne). 2025 Jun 25;12:1591287. doi: 10.3389/fmed.2025.1591287. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40636378 Free PMC article. Review.
-
Expansion of hematopoietic stem cells for transplantation: current perspectives.Exp Hematol Oncol. 2012 May 14;1(1):12. doi: 10.1186/2162-3619-1-12. Exp Hematol Oncol. 2012. PMID: 23210618 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources